Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2014197520) NOVEL FORMULATIONS OF BOTANICAL EXTRACTS FOR CANCER THERAPY
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2014/197520 International Application No.: PCT/US2014/040771
Publication Date: 11.12.2014 International Filing Date: 03.06.2014
IPC:
A61K 36/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Applicants:
GENYOUS BIOMED INTERNATIONAL [US/US]; Suite 600 303 Twin Dolphin Drive Redwood Shores, California 94065, US
Inventors:
DAO, James; US
DAO, Jeffery; US
DAO, Thomas; US
KWOK, David; CA
Agent:
BASU, Shantanu; US
Priority Data:
61/830,63203.06.2013US
Title (EN) NOVEL FORMULATIONS OF BOTANICAL EXTRACTS FOR CANCER THERAPY
(FR) NOUVELLES FORMULATIONS D'EXTRAITS BOTANIQUES POUR THÉRAPIE CANCÉREUSE
Abstract:
(EN) Novel formulations are disclosed of a therapeutically effrective composition comprising two or more of an extract of Ganoderma lucidum, an extract of Salvia miltiorrhiza, an extract of Scutellaria barbata, and/or an extract of Scutellaria baicalensis wherein each extract comprises about 1 to about 90 percent by weight. Extracts are made in aqueous solvents, alcohol solvents and non-alcoholic organic solvents. Formulations comprising one or more emulsifiers demonstrating higher bioavailablity and maximum tolerated dose are provided.
(FR) La présente invention concerne de nouvelles formulations d'une composition thérapeutiquement efficace comprenant deux composants ou plus parmi les composants suivants : un extrait de Ganoderma lucidum, un extrait de Salvia miltiorrhiza, un extrait de Scutellaria barbata, et/ou un extrait de Scutellaria baicalensis, chaque extrait comprenant entre environ 1 et environ 90 pour cent en poids du composant. Lesdits extraits sont constitués en solvants aqueux, solvants alcooliques et solvants organiques non-alcooliques. L'invention porte en outre sur des formulations comprenant un ou plusieurs émulsifiants supérieurs en termes de biodisponibilité et de dose maximale tolérée.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)